2 studies found for:    20650435 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction (AMI) Patients According to CYP2C19 Polymorphism
Condition: Myocardial Infarction
Interventions: Drug: cilostazol;   Drug: clopidogrel (Plavix);   Genetic: CYP2C19;   Drug: aspirin (Acetylsalicylic acid)
2 Unknown  Comparison of Platelet Inhibition With Adjunctive Cilostazol Versus High Maintenance-Dose Clopidogrel According to Hepatic Cytochrome 2C19 Allele (CYP2C19) Polymorphism
Conditions: Coronary Artery Stenosis;   Maximal Platelet Aggregation;   Late Platelet Aggregation;   High Post-Treatment Platelet Reactivity
Interventions: Drug: cilostazol;   Drug: clopidogrel;   Drug: aspirin

Indicates status has not been verified in more than two years